AC Immune SA ACIU
Updated: 10 Aug 2026
No signal published yet
We already track AC Immune SA and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow AC Immune SA? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow AC Immune SA free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 5, 2026, AC Immune issued its first-half 2026 financial and corporate update, reporting CHF 75.4 million in liquidity, projected to fund operations into the fourth quarter of 2027. The company highlighted clinical updates across its pipeline alongside a $12 million milestone payment triggered by collaboration partner Takeda.
What Firelda Watch includes for AC Immune SA
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow AC Immune SA? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow AC Immune SA free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more